To demonstrate that this response is mediated through a SAP-dependent pathway and not through CD3, we cocultured healthy donor and noncorrected and corrected T cells from patients with XLP1 against p815 tumor cells incubated with soluble CD3 (Fig 5). This evidence concerns the gene SH2D1A and neoplasm.